Us Biomax

Vulval disease spectrum (vulva cancer progression) tissue array, 46 cases/100 cores

Vulval disease spectrum (vulva cancer progression) tissue array, 46 cases/100 cores

Vulva cancer tissue array, including TNM, clinical stage and pathology diagnosis, replacing UV241

Vulva cancer tissue array, including TNM, clinical stage and pathology diagnosis, replacing UV241

Vermiform appendix disease spectrum (vermiform appendix tumor progression) tissue array, 50 cases/100 cores

Vermiform appendix disease spectrum (vermiform appendix tumor progression) tissue array, 50 cases/100 cores

Uterus tumor tissue array, including pathology grade, TNM and clinical stage, 20 cases/20 cores

Uterus tumor tissue array, including pathology grade, TNM and clinical stage, 20 cases/20 cores

Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores

Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores

Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores

Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores

Uterine endometrial cancer tissue array with normal tissue from autopsy, 12 cases/24 cores, with TNM data

Uterine endometrial cancer tissue array with normal tissue from autopsy, 12 cases/24 cores, with TNM data

Uterine cervix disease spectrum tissue array, including TNM, clinical stage and pathology grade, 60 cases/ 60 cores, replacing CR602

Uterine cervix disease spectrum tissue array, including TNM, clinical stage and pathology grade, 60 cases/ 60 cores, replacing CR602

Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases/24 cores, replacing CR241

Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases/24 cores, replacing CR241

Uterine cervix cancer and normal tissue array, with grade and stage data, 24 cases/72 cores

Uterine cervix cancer and normal tissue array, with grade and stage data, 24 cases/72 cores

Uterine cervical cancer survey tissue array (5 of 5), including pathology grade, TNM, clinical stage and IHC marker (P16 and HPV) , 104 cases/208 cores

Uterine cervical cancer survey tissue array (5 of 5), including pathology grade, TNM, clinical stage and IHC marker (P16 and HPV) , 104 cases/208 cores

Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases/208 cores

Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases/208 cores

Uteral leiomyoma (hysteromyoma) tissue array, 30 cases/60 cores

Uteral leiomyoma (hysteromyoma) tissue array, 30 cases/60 cores

Uteral cancer (multi-types of uterine carcinomas and diseases) tissue array, 80 cases/80 cores

Uteral cancer (multi-types of uterine carcinomas and diseases) tissue array, 80 cases/80 cores

Ureter and urethra disease spectrum tissue array, with stage, grade and TNM data, 50 cases/100 cores

Ureter and urethra disease spectrum tissue array, with stage, grade and TNM data, 50 cases/100 cores

Tumor tissue array, 2 cores/case. NAT.

Tumor tissue array, 2 cores/case. NAT.

Triple negative breast cancer tissue array, including TNM, clinical stage and pathology grade, majority cases with negative of ER, PR, Her-2 in IHC, 48 cases/ 48 cores, replaced by BR487d

Triple negative breast cancer tissue array, including TNM, clinical stage and pathology grade, majority cases with negative of ER, PR, Her-2 in IHC, 48 cases/ 48 cores, replaced by BR487d

Transitional cell carcinomo of renal pelvis tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores

Transitional cell carcinomo of renal pelvis tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores

Top 4 types of cancer (colon, breast, prostate and lung) tissue microarray, 48 case/48 cores, with grade, Gleason score and stage data

Top 4 types of cancer (colon, breast, prostate and lung) tissue microarray, 48 case/48 cores, with grade, Gleason score and stage data

Top 4 types of cancer (colon, breast, prostate and lung) 48 core tissue array, 48 cases/48 cores

Top 4 types of cancer (colon, breast, prostate and lung) 48 core tissue array, 48 cases/48 cores

Top 4 types of cancer (colon, breast, lung and prostate) tissue microarray, 22 cases/48 cores, plus grade, stage and Gleason Score information

Top 4 types of cancer (colon, breast, lung and prostate) tissue microarray, 22 cases/48 cores, plus grade, stage and Gleason Score information

Top 4 types of cancer (colon, breast, lung and prostate) tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing TP241

Top 4 types of cancer (colon, breast, lung and prostate) tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing TP241

Top 4 types of cancer (colon, breast, lung and prostate) tissue array with normal tissue, including TNM and pathology grade, 24cases/ 24 cores, replacing TP242c

Top 4 types of cancer (colon, breast, lung and prostate) tissue array with normal tissue, including TNM and pathology grade, 24cases/ 24 cores, replacing TP242c

Tonsil disease spectrum tissue array, 50 cases/100 cores

Tonsil disease spectrum tissue array, 50 cases/100 cores

Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases/100 cores

Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases/100 cores

Tissue microarray of top 4 types of cancer (colon, breast, prostate and lung) and normal tissue, 24 cases/48 cores

Tissue microarray of top 4 types of cancer (colon, breast, prostate and lung) and normal tissue, 24 cases/48 cores

Tissue microarray of normal human respiratory tract, 32 cases/32 cores

Tissue microarray of normal human respiratory tract, 32 cases/32 cores

Tissue microarray of bladder cancer and normal tissue, high density (69 cases/208 cores) with grade and stage data

Tissue microarray of bladder cancer and normal tissue, high density (69 cases/208 cores) with grade and stage data

Tissue array of rectal adenocarcinoma and matched adjacent tissue, 12 cases/48 cores

Tissue array of rectal adenocarcinoma and matched adjacent tissue, 12 cases/48 cores

Tissue array of ovarian granulosa-theca cell tumor (GTCT, malignant and benign) and cysts, 60 cases/60 cores

Tissue array of ovarian granulosa-theca cell tumor (GTCT, malignant and benign) and cysts, 60 cases/60 cores

Tissue array of lung carcinoma and matched adjacent tissue, 12 cases/48 cores

Tissue array of lung carcinoma and matched adjacent tissue, 12 cases/48 cores

Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases/48 cores

Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases/48 cores

Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases/48 cores

Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases/48 cores

Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases/48 cores

Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases/48 cores

Thyroid papillary carcinoma tissue array, 58 cases. Normal thyroid, 4 cases.

Thyroid papillary carcinoma tissue array, 58 cases. Normal thyroid, 4 cases.

Thyroid papillary carcinoma tissue array (31 cases). Tumor and matched NAT.

Thyroid papillary carcinoma tissue array (31 cases). Tumor and matched NAT.

Thyroid papillary cancer tissue array, 80 cases/80 cores

Thyroid papillary cancer tissue array, 80 cases/80 cores

Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases/80 cores, replacing TH809

Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases/80 cores, replacing TH809

Thyroid medullary carcinoma tissue array, including TNM and clinical stage, 40 cases/ 40 cores

Thyroid medullary carcinoma tissue array, including TNM and clinical stage, 40 cases/ 40 cores

Thyroid medullary cancer tissue array and normal tissues, 40 cases/80 cores, with grade and stage data

Thyroid medullary cancer tissue array and normal tissues, 40 cases/80 cores, with grade and stage data

Thyroid gland tumor test tissue with normal tissue array, including TNM and clinical stage, 6 cases/24 cores, replacing T153

Thyroid gland tumor test tissue with normal tissue array, including TNM and clinical stage, 6 cases/24 cores, replacing T153

Thyroid gland cancer tissue array with normal thyroid gland tissue, including TNM and clinical stage, 80 cases/80 cores, replacing TH8010

Thyroid gland cancer tissue array with normal thyroid gland tissue, including TNM and clinical stage, 80 cases/80 cores, replacing TH8010

Thyroid disease tissue array, including TNM, clinical stage, 48 cases/ 96 cores

Thyroid disease tissue array, including TNM, clinical stage, 48 cases/ 96 cores

Thyroid disease spectrum tissue array, including TNM, clinical stage, 20 cases/ 20 cores

Thyroid disease spectrum tissue array, including TNM, clinical stage, 20 cases/ 20 cores

Thyroid disease spectrum tissue array, 75 cases/80 cores

Thyroid disease spectrum tissue array, 75 cases/80 cores

Thyroid carcinoma tissue array, 28 cases. Tumor and matched normal adjacent tissue. Normal thyroid, 4 cases.

Thyroid carcinoma tissue array, 28 cases. Tumor and matched normal adjacent tissue. Normal thyroid, 4 cases.

Thyroid cancer tissue microarray with normal tissue control, high density (69 cases/208 cores), with clinical stage data

Thyroid cancer tissue microarray with normal tissue control, high density (69 cases/208 cores), with clinical stage data

Thyroid cancer tissue array, including TNM and pathology grade, 6 cases/24 cores

Thyroid cancer tissue array, including TNM and pathology grade, 6 cases/24 cores

Thyroid cancer tissue array with unmatched normal adjacent tissues, 48 cases/48 cores, with grade and stage info

Thyroid cancer tissue array with unmatched normal adjacent tissues, 48 cases/48 cores, with grade and stage info

Thyroid cancer tissue array with self-matching normal adjacent tissues, 10 cases/24 cores

Thyroid cancer tissue array with self-matching normal adjacent tissues, 10 cases/24 cores

Thyroid cancer tissue array with matched or unmatched cancer adjacent tissue, including TNM, clinical stage and pathology grade, 74 cases/80 cores, replacing TH801a

Thyroid cancer tissue array with matched or unmatched cancer adjacent tissue, including TNM, clinical stage and pathology grade, 74 cases/80 cores, replacing TH801a

Thyroid cancer tissue array with matched or unmatched adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 74 cases/80 cores, replaced by TH801b

Thyroid cancer tissue array with matched or unmatched adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 74 cases/80 cores, replaced by TH801b